[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853
Sort by:

Opioid Induced Side Effects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Opioid Induced Side Effects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Opioid Induced Side Effects Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 48 pages

Opioid Receptor (OPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Opioid Receptor (OPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Opioid Receptor (OPR) Drugs in Development by Therapy Areas and Ind...

May 2022 283 pages

Opium Withdrawal Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Opium Withdrawal Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Opium Withdrawal Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 39 pages

Optic Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Optic Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Optic Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 37 pages

Oral Cavity (Mouth) Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Oral Cavity (Mouth) Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Oral Cavity (Mouth) Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 83 pages

Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SU...

May 2022 41 pages

Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Ornithine Decarboxylase (ODC or ODC1...

May 2022 37 pages

Oropharyngeal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Oropharyngeal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Oropharyngeal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 35 pages

Osteopetrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Osteopetrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Osteopetrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 35 pages

Otitis Externa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Otitis Externa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Otitis Externa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 37 pages

Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...

May 2022 36 pages

Oxytocin Receptor (OTR or OXTR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Oxytocin Receptor (OTR or OXTR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Oxytocin Receptor (OTR or OXTR) Drugs in Development by T...

May 2022 56 pages

P27 (Negative Regulatory Factor or Nef) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

P27 (Negative Regulatory Factor or Nef) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY P27 (Negative Regulatory Factor or Nef) Drugs in...

May 2022 41 pages

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Dru...

May 2022 45 pages

p38 MAP Kinase (EC 2.7.11.24) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

p38 MAP Kinase (EC 2.7.11.24) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY p38 MAP Kinase (EC 2.7.11.24) Drugs in Development by Thera...

May 2022 63 pages

Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players S...

May 2022 38 pages

Pancreatic Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pancreatic Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pancreatic Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 81 pages

Pancreatic Ductal Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Pancreatic Ductal Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pancreatic Ductal Adenocarcinoma Drugs in Development by Stages, Target, MoA, R...

May 2022 254 pages

Pancreatic Endocrine Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pancreatic Endocrine Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pancreatic Endocrine Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 37 pages

Pancreatic Islet Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pancreatic Islet Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pancreatic Islet Transplant Rejection Drugs in Development by Stages, Targ...

May 2022 41 pages

Pandemic Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pandemic Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pandemic Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 81 pages

Panic Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Panic Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Panic Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 38 pages

Papillary Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Papillary Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Papillary Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 42 pages

Papillary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Papillary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Papillary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 64 pages

Papillary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Papillary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Papillary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 36 pages

Paraganglioma (Glomus Jugulare Tumor) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Paraganglioma (Glomus Jugulare Tumor) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Paraganglioma (Glomus Jugulare Tumor) Drugs in Development by Stages, Targ...

May 2022 42 pages

Paralysis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Paralysis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Paralysis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 44 pages

Paramyxoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Paramyxoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Paramyxoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 249 pages

Paranasal Sinus And Nasal Cavity Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Paranasal Sinus And Nasal Cavity Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Paranasal Sinus And Nasal Cavity Cancer Drugs in Development by Stages,...

May 2022 40 pages

Parathyroid Hormone-Parathyroid Hormone Related Peptide Receptor (PTH-PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Parathyroid Hormone-Parathyroid Hormone Related Peptide Receptor (PTH-PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) Drugs in Development by Therapy Areas and Indications, Stages, M...

May 2022 38 pages

Partial Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Partial Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Partial Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 46 pages

Pediatric Diffuse Intrinsic Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pediatric Diffuse Intrinsic Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pediatric Diffuse Intrinsic Pontine Glioma Drugs in Development by St...

May 2022 88 pages

Pemphigus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pemphigus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pemphigus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 48 pages

Penicillin Binding Protein 2 (PBP2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Penicillin Binding Protein 2 (PBP2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Penicillin Binding Protein 2 (PBP2) Drugs in Developm...

May 2022 40 pages

Penile Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Penile Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Penile Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 70 pages

Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Peptidyl Prolyl Cis Trans Isomerase (EC...

May 2022 49 pages

Periodontal Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Periodontal Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Periodontal Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 62 pages

Periostin (Osteoblast Specific Factor 2 or POSTN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Periostin (Osteoblast Specific Factor 2 or POSTN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Periostin (Osteoblast Specific Factor 2...

May 2022 37 pages

Peripheral Artery Occlusive Disease (PAOD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Peripheral Artery Occlusive Disease (PAOD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral Artery Occlusive Disease (PAOD) Drugs in Development by St...

May 2022 84 pages

Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Peripher...

May 2022 36 pages

Peripheral Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Peripheral Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 39 pages

Peripheral Neuropathic Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Peripheral Neuropathic Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral Neuropathic Pain Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 122 pages

Peripheral Neuropathy (Sensory Neuropathy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Peripheral Neuropathy (Sensory Neuropathy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral Neuropathy (Sensory Neuropathy) Drugs in Development by St...

May 2022 74 pages

Peripheral T-Cell Lymphomas (PTCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peripheral T-Cell Lymphomas (PTCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral T-Cell Lymphomas (PTCL) Drugs in Development by Stages, Target, Mo...

May 2022 165 pages

Peroxisome Proliferator Activated Receptor Alpha (Nuclear Receptor Subfamily 1 Group C Member 1 or NR1C1 or PPARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peroxisome Proliferator Activated Receptor Alpha (Nuclear Receptor Subfamily 1 Group C Member 1 or NR1C1 or PPARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Typ...

May 2022 56 pages

Peroxisome Proliferator Activated Receptor Gamma (Nuclear Receptor Subfamily 1 Group C Member 3 or NR1C3 or PPARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peroxisome Proliferator Activated Receptor Gamma (Nuclear Receptor Subfamily 1 Group C Member 3 or NR1C3 or PPARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Typ...

May 2022 71 pages

Persistent Corneal Epithelial Defects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Persistent Corneal Epithelial Defects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Persistent Corneal Epithelial Defects Drugs in Development by Stages, Targ...

May 2022 40 pages

Pervasive Developmental Disorder (PDD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Pervasive Developmental Disorder (PDD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pervasive Developmental Disorder (PDD) Drugs in Development by Stages, Ta...

May 2022 173 pages

Phosphatidylinositol 3 Kinase (PI3K or EC 2.7.1.137) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Phosphatidylinositol 3 Kinase (PI3K or EC 2.7.1.137) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Phosphatidylinositol 3 Kinase (PI3K...

May 2022 170 pages

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (PI3K-Delta or Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.137 or EC 2.7.1.153) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (PI3K-Delta or Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.137 o...

May 2022 79 pages

Filters

Search

Categories

2,264
2,910
126
9
6
1
1
1
4
522
3
6

Publishers

5,853

Regions

5,853

Price

Date

Pages

Offers